HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β.
breast cancer
interleukin-1β
interleukin-6 and oncostatin M
metastasis
oncostatin M
Journal
Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965
Informations de publication
Date de publication:
12 Mar 2019
12 Mar 2019
Historique:
received:
12
10
2018
accepted:
31
01
2019
entrez:
23
4
2019
pubmed:
23
4
2019
medline:
23
4
2019
Statut:
epublish
Résumé
Chronic inflammation has been recognized as a risk factor for the development and maintenance of malignant disease. Cytokines such as interleukin-6 (IL-6), oncostatin M (OSM), and interleukin-1 beta (IL-1β) promote the development of both acute and chronic inflammation while promoting
Identifiants
pubmed: 31007849
doi: 10.18632/oncotarget.26699
pii: 26699
pmc: PMC6459341
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2068-2085Subventions
Organisme : NIGMS NIH HHS
ID : R25 GM123927
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103408
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM109095
Pays : United States
Organisme : NCRR NIH HHS
ID : P20 RR016454
Pays : United States
Organisme : NCI NIH HHS
ID : R15 CA137510
Pays : United States
Déclaration de conflit d'intérêts
CONFLICTS OF INTEREST The authors declare that they have no conflicts of interest.
Références
Circ Res. 1999 Dec 3-17;85(12):1124-31
pubmed: 10590238
Cancer Invest. 2000;18(4):293-302
pubmed: 10808364
J Neurochem. 2000 Aug;75(2):563-75
pubmed: 10899931
Breast Cancer Res Treat. 2001 Mar;66(2):111-21
pubmed: 11437097
Arthritis Rheum. 2001 Jul;44(7):1620-32
pubmed: 11465713
J Immunol. 2002 Nov 1;169(9):5244-51
pubmed: 12391243
Int J Cancer. 2003 Feb 20;103(5):642-6
pubmed: 12494472
Int J Oncol. 2003 Aug;23(2):269-84
pubmed: 12851675
J Biol Chem. 2004 Jan 16;279(3):1768-76
pubmed: 14593105
Oncogene. 2003 Nov 6;22(50):8117-24
pubmed: 14603252
Arthritis Rheum. 2003 Dec;48(12):3404-18
pubmed: 14673992
Clin Exp Metastasis. 2004;21(2):167-76
pubmed: 15168734
Adv Protein Chem. 2004;68:107-46
pubmed: 15500860
Cytokine. 2005 Aug 21;31(4):251-7
pubmed: 16043358
Cancer Res. 2005 Oct 1;65(19):8896-904
pubmed: 16204061
Arthritis Rheum. 2006 Feb;54(2):540-50
pubmed: 16447230
J Cell Physiol. 2006 Jun;207(3):683-8
pubmed: 16453302
Cytokine. 2006 Mar 21;33(6):323-36
pubmed: 16713283
Cancer Metastasis Rev. 2006 Sep;25(3):387-408
pubmed: 17043764
Am J Obstet Gynecol. 2007 Apr;196(4):394.e1-11; discussion 394.e11-3
pubmed: 17403432
Nat Med. 2008 May;14(5):518-27
pubmed: 18438415
Endocrinology. 2008 Dec;149(12):6272-9
pubmed: 18703630
Int J Oncol. 2009 Mar;34(3):821-8
pubmed: 19212687
Oncogene. 2009 Jul 30;28(30):2745-55
pubmed: 19483720
Mol Cancer Res. 2009 Jun;7(6):966-76
pubmed: 19491198
Oncogene. 2009 Aug 20;28(33):2940-7
pubmed: 19581928
Cytokine Growth Factor Rev. 2010 Feb;21(1):11-9
pubmed: 20018552
Cancer Metastasis Rev. 2010 Jun;29(2):317-29
pubmed: 20422276
Mol Cancer. 2010 Apr 30;9:97
pubmed: 20433747
J Leukoc Biol. 2010 Dec;88(6):1145-56
pubmed: 20610800
BMC Cancer. 2011 Apr 11;11:125
pubmed: 21481226
Cancer Manag Res. 2011;3:177-89
pubmed: 21625400
J Pathol. 2011 Nov;225(3):448-62
pubmed: 21952923
Oncogene. 2012 Jul 19;31(29):3467-81
pubmed: 22105366
Endocr Relat Cancer. 2012 Apr 10;19(2):181-95
pubmed: 22267707
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
Invest New Drugs. 2013 Jun;31(3):669-76
pubmed: 22828917
Genes Cancer. 2012 Feb;3(2):117-30
pubmed: 23050044
Future Oncol. 2012 Nov;8(11):1427-42
pubmed: 23148616
Mol Cancer Res. 2013 Oct;11(10):1159-65
pubmed: 23867565
Cancer Cell Int. 2013 Sep 03;13(1):89
pubmed: 24004445
Cytokine Growth Factor Rev. 2013 Dec;24(6):503-13
pubmed: 24210902
Neoplasma. 2014;61(2):205-12
pubmed: 24299316
Clin Cancer Res. 2014 Apr 15;20(8):2192-204
pubmed: 24563479
J Pathol. 2014 Mar;232(4):386-90
pubmed: 24659184
Cytokine. 2014 Aug;68(2):101-9
pubmed: 24767864
J Interferon Cytokine Res. 2015 Jan;35(1):1-16
pubmed: 25068787
Cancer Res. 2014 Dec 1;74(23):6806-19
pubmed: 25252914
Am J Pathol. 2015 Mar;185(3):765-75
pubmed: 25559270
Cytokine. 2015 Mar;72(1):71-85
pubmed: 25622278
Turk J Med Sci. 2015;45(1):112-7
pubmed: 25790539
PLoS One. 2015 Jun 01;10(6):e0127230
pubmed: 26030441
Tumori. 2015 Sep-Oct;101(5):535-41
pubmed: 26045123
J Nucl Med. 2015 Aug;56(8):1144-9
pubmed: 26069310
Oncotarget. 2016 Mar 29;7(13):15460-73
pubmed: 26840088
Annu Rev Pathol. 2016 May 23;11:421-49
pubmed: 27193454
Oncotarget. 2016 Nov 15;7(46):75571-75584
pubmed: 27765923
Curr Opin Pharmacol. 2016 Dec;31:90-96
pubmed: 27875786
Curr Opin Pharmacol. 2016 Dec;31:114-122
pubmed: 27889687
J Clin Oncol. 2016 Dec 10;34(35):4270-4276
pubmed: 27903155
Immunol Cell Biol. 2017 Apr;95(4):325-332
pubmed: 27999432
Mol Cancer Res. 2017 Apr;15(4):478-488
pubmed: 28053127
Cancer Res. 2017 Mar 1;77(5):1179-1187
pubmed: 28249935
Int J Cancer. 2017 Jun 15;140(12):2657-2666
pubmed: 28268252
Oncogene. 2017 Jul 13;36(28):4001-4013
pubmed: 28288136
Oncol Lett. 2017 Feb;13(2):955-960
pubmed: 28356984
Adv Clin Exp Med. 2017 May-Jun;26(3):421-426
pubmed: 28791816
Lancet. 2017 Oct 21;390(10105):1833-1842
pubmed: 28855077
Cancer Res. 2017 Nov 1;77(21):6033-6041
pubmed: 28935814
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Breast Cancer Res. 2018 Jun 14;20(1):53
pubmed: 29898744
Cancer Res. 2018 Sep 15;78(18):5243-5258
pubmed: 30012670
Cancer Res. 2018 Sep 15;78(18):5200-5202
pubmed: 30217872
Transl Oncol. 2019 Feb;12(2):245-255
pubmed: 30439625
Cancer Manag Res. 2018 Nov 29;10:6517-6523
pubmed: 30555257
Endocrinology. 1995 Nov;136(11):4790-5
pubmed: 7588208
Nucleic Acids Res. 1997 Jun 15;25(12):2424-9
pubmed: 9171095